Literature DB >> 12141274

Second generation antipsychotics.

W Wolfgang Fleischhacker.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12141274     DOI： 10.1007/s00213-002-1064-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  9 in total

1.  An atypical compound by any other name is still a.

Authors:  H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2000-01       Impact factor: 4.530

2.  Atypical antipsychotics: an inspiring but confusing concept

Authors: 
Journal:  Psychopharmacology (Berl)       Date:  2000-01       Impact factor: 4.530

3.  Non-equipotent doses partly explain differences among antipsychotics - implications of PET studies.

Authors:  S Nyberg; L Farde
Journal:  Psychopharmacology (Berl)       Date:  2000-01       Impact factor: 4.530

4.  A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone database.

Authors:  W W Fleischhacker; P Lemmens; B van Baelen
Journal:  Pharmacopsychiatry       Date:  2001-05       Impact factor: 5.788

Review 5.  Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.

Authors:  J Geddes; N Freemantle; P Harrison; P Bebbington
Journal:  BMJ       Date:  2000-12-02

6.  Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.

Authors:  D L Zimbroff; J M Kane; C A Tamminga; D G Daniel; R J Mack; P J Wozniak; T B Sebree; B A Wallin; K B Kashkin
Journal:  Am J Psychiatry       Date:  1997-06       Impact factor: 18.112

Review 7.  Atypical antipsychotics: are some more atypical than others?

Authors:  G Remington; S Kapur
Journal:  Psychopharmacology (Berl)       Date:  2000-01       Impact factor: 4.530

8.  Extrapyramidal side effects of clozapine and haloperidol.

Authors:  M Kurz; M Hummer; H Oberbauer; W W Fleischhacker
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

9.  Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose.

Authors:  J P McEvoy; G E Hogarty; S Steingard
Journal:  Arch Gen Psychiatry       Date:  1991-08
  9 in total
  2 in total

Review 1.  Understanding antipsychotic "atypicality": a clinical and pharmacological moving target.

Authors:  Gary Remington
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

Review 2.  Augmentation strategies in clozapine-resistant schizophrenia.

Authors:  Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.